Blood pressure control in patients with comorbidities

Area of Science:

• Cardiology
• Endocrinology
• Metabolic Disorders

Background:

• Hypertension often coexists with obesity, diabetes, hyperlipidemia, and metabolic syndrome, increasing cardiovascular disease risk.
• These comorbidities predispose patients to target organ damage (TOD), necessitating stringent blood pressure (BP) control targets.
• Current clinical guidelines recommend strict BP targets for hypertensive patients with comorbidities.

Purpose of the Study:

• To highlight the challenges in achieving target BP in hypertensive patients with comorbidities.
• To emphasize the need for effective 24-hour BP control in this population.
• To discuss the limitations of current antihypertensive treatments in managing these complex patients.

Main Methods:

• Review of clinical trial and real-life evidence regarding BP control in hypertensive patients with comorbidities.
• Analysis of factors contributing to difficulties in achieving target BP.
• Evaluation of the role of 24-hour BP monitoring and combination therapy.

Main Results:

• Target BP levels are difficult to achieve in hypertensive patients with metabolic comorbidities.
• These patients often require combination therapy, but physicians may hesitate to adjust medication regimens.
• Nondipping status, a risk factor for TOD and mortality, is more common in this population.
• Not all antihypertensives provide effective 24-hour BP control, and some can worsen metabolic issues.

Conclusions:

• Effective 24-hour BP control is crucial for hypertensive patients with obesity, diabetes, or metabolic syndrome.
• Overcoming physician reluctance to intensify therapy is essential for guideline adherence.
• Careful selection of antihypertensives is needed to ensure efficacy and avoid metabolic complications.